| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock, $0.0001 par value | 0 | $0.9100 | 06 Jun 2023 | Direct | |
| Satsuma Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (right to buy) | 0 | 08 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323014901-o-neil-thomas-p-2023-06-06 | Satsuma Pharmaceuticals, Inc. | 06 Jun 2023 | 6 | -$12,628 | 4 | Chief Financial Officer | 08 Jun 2023, 16:48 |
| /report/000156761922012481-o-neil-thomas-p-2022-06-03 | Satsuma Pharmaceuticals, Inc. | 03 Jun 2022 | 1 | $0 | 4 | Chief Financial Officer | 07 Jun 2022, 17:40 |